Successful delivery of a Covid-19 vaccine in early 2021 would be an unprecedented achievement in vaccine development history. While vaccine trials are still underway, the supply chain race is on to determine how to inoculate 70% of the world's population, a population of over 5.5 billion people. This panel discussion explores how the pharmaceutical industry can collaborate with key stakeholders to build a robust supply chain from the ground up. This is in a market where the sheer speed of execution and monumental volume are top priorities, yet demand grossly exceeds supply. About the panelists David Simchi-Levi is a Professor of Engineering Systems at MIT and the Co-Director of Leaders for Global Operations. His research currently focuses on developing and implementing robust and efficient techniques for logistics and manufacturing systems. He has published widely in professional journals on both practical and theoretical aspects of logistics and supply chain management. Professor Simchi-Levi is widely regarded as one of the most well-respected supply chain thinkers in the world. His involvement with various technology firms and research with world-leading manufacturers means his influence is felt throughout the supply chain profession. Professor Simchi-Levi has also published several seminal books which are used by consultants and supply chain professionals alike for reference to this day. As the Chief Digital Transformation Officerof TraceLink, Roddy Martin is responsible for guiding TraceLink's business transformation initiatives through his expertise and insight into change management and end-to-end digital supply chain strategy. As a recognized industry thought-leader and influencer, Martin has over 36 years of experience advising organizations on implementing end-to-end business operating models in their supply chains through digital transformation, segmentation, and change management. He works closely with senior global leaders and executives from multiple industry verticals. He has detailed experience transforming healthcare and consumer products value chains from point-of-sale to the supply network and manufacturing. Mirko Senatore has been with Pfizer since 2007, holding several key roles in the EMEA Supply Chain organization that brought him to lead both strategic transformational initiatives and operational teams throughout a 13 years tenure. His current position is Global Supply Chain Lead – Eastern Europe and Central Asia. In this role, Mirko oversees the region's transformation and follows mergers, acquisitions, divestitures, and new product launches, including launching the disruptive Covid-19 vaccine. Mirko holds a Master's degree in Business Economics from Università Degli Studi di Salerno (Italy), an MSc in Logistics & Supply Chain Management from the Cranfield University (UK), and an Executive MBA from the Quantic School of Business & Technology (US).

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related